LONDON (AP) – A British drug regulator is urging people to continue taking AstraZeneca coronavirus vaccines despite the discovery that seven people in the UK have died from a rare blood clot after being bitten.
The Drug Enforcement Agency, or MHRA, said it was unclear whether the shootings caused blood clots, that it was “an ongoing study of rare, specific blood type tissue in UK reports.”
Although the agency reported late Friday that seven people had died from a blood clot, it did not provide any information on their age or health.
In all, the MHRA said it had identified 30 rare cases of blood clots out of the 18.1 million doses of AstraZeneca that had been administered by March 24. The risk of this type of thrombus is “very small”.
“The benefits of the COVID-19 vaccine AstraZeneca in the prevention of COVID-19 infection, its complications continue to outweigh any risk, and the public should continue to receive the vaccine when invited,” said Dr. June Un Raine, CEO of the agency.
Concerns about the AstraZeneca vaccine have already prompted some countries, including Canada, France, Germany and the Netherlands, to limit its use for the elderly.
The UK, which has developed faster coronavirus vaccines than other European countries, is particularly dependent on the AstraZeneca vaccine, developed by scientists at Oxford University. It also uses a vaccine developed by Pfizer-BioNTech, the agency of which has not seen any case of blood clots.
Saturday’s figures showed the UK had given the first dose of the vaccine to 31.4 million people, or about 46% of its population, much higher than in the rest of Europe. The delivery of the second dose is a priority for April, 5.2 million people have now received two strokes.
The relative success of the country’s immunization program has been credited with helping to drastically reduce new coronavirus infections in the UK after the winter break, paving the way for a modest easing of blockade restrictions.
The UK reported 3,423 infections on Saturday, up slightly from the previous six-month low of 3,402. It also recorded only 10 deaths from the coronavirus, the lowest daily average since early September.
Despite the improved coronavirus background, the UK has the highest COVID-related mortality in Europe at more than 126,500.
In France, which has restricted the use of the AstraZeneca vaccine to people over the age of 55, the family of a 38-year-old woman who died after suffering from post-vaccination brain tissue filed a criminal case in Toulouse on Saturday demanding an investigation into the murder. ,
He is one of four people in France who died a few weeks after receiving a blood transfusion after receiving the AstraZeneca vaccine. The French National Agency for Medical Safety says it is investigating eight other cases where heavy blood clots were found in survivors.
The MHRA’s view on the relative benefits of the vaccine is shared by the European Medicines Agency. It says the causal link between the unusual blood clots of people who have been vaccinated with AstraZeneca is “not proven, but it is possible” that the benefits of the vaccine outweigh the risks of side effects. The World Health Organization has also urged countries to continue using the cavity.
Adam Finn, a professor of pediatrics at the University of Bristol, says the “extreme rarity” of blood clotting in the context of millions of strokes in the UK makes the decision very clear.
“Getting the vaccine is by far the safest choice in terms of minimizing the risk of serious illness or death,” he said.
This report was supported by Angela Charlton of Paris.
Follow the AP Epidemic Coverage: